By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Protein analysis firm Cell Biosciences today said it has entered into a definitive agreement to buy Convergent Bioscience for $12 million in a cash deal.

The deal is expected to expand Cell Biosciences' protein analysis product portfolio "and transform Cell Biosciences into the premier provider of capillary-based protein analysis technology," the Santa Clara, Calif.-based company said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.